Comparing two cholesterol drugs and vitamin D levels after heart attack-related conditions
Compares atorvastatin and rosuvastatin effects on vitamin D in adults with acute coronary syndrome.
Plain-language title generated from the registry record
Registry title: Impact of Atorvastatin Versus Rosuvastatin on 25 Hydroxy Vitamin D Levels in Patients With Acute Coronary Syndrome
Key facts
- Where
- Lahore, PakistanSee the site
- Phase
- Phase 4
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Source: NCT06765265, who can take part
Where in Pakistan
- King Edward Medical UniversityLahore, PakistanTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- King Edward Medical University
- Trial code
- NCT06765265
- Record updated
- 11 March 2025
- Original description
there will be 2 groups of patients with acute coronary syndrome. The patients will receive one of the 2 study drugs and impact on raising Vitamin D level will be seen after 6 monthsRead full original descriptionShow less
Impact of Atorvastatin Versus Rosuvastatin on 25 Hydroxy Vitamin D Levels in Patients With Acute Coronary Syndrome
there will be 2 groups of patients with acute coronary syndrome. The patients will receive one of the 2 study drugs and impact on raising Vitamin D level will be seen after 6 months
Inclusion: Acute Coronary Syndrome; 25 OH-Vitamin D levels between 30-70ng/ml.
Exclusion: Use of following within last 3 months (Vitamin D Supplements, lipid lowering drugs, anti-obesity drugs, corticosteroids); hypersensitivity to statins; Hypercalcemia; hypocalcemia; pregnancy; lactation; hypothyroidism; Deranged LFTs \& RFTs.